Effects of alcohol on the composition and metabolism of the intestinal microbiota among people with HIV: a cross-sectional study

Ni-Ni Qiao,Quan Fang,Xin-Hong Zhang,Su-Su Ke,Zi-Wei Wang,Gan Tang,Rui-Xue Leng,Yin-Guang Fan,Ni-ni Qiao,Xin-hong Zhang,Su-su Ke,Zi-wei Wang,Rui-xue Leng,Yin-guang Fan
DOI: https://doi.org/10.1016/j.alcohol.2024.02.003
IF: 2.558
2024-02-22
Alcohol
Abstract:Objectives Alcohol consumption is not uncommon among people with HIV (PWH) and may exacerbate HIV-induced intestinal damage, and further lead to dysbiosis and increased intestinal permeability. This study aimed to determine the changes in the faecal microbiota and its association with alcohol consumption in HIV-infected patients. Methods A cross-sectional survey was conducted between November 2021 and May 2022, and 93 participants were recruited. To investigate the alterations of alcohol misuse on fecal microbiology in HIV-infected individuals, we performed 16s rDNA gene sequencing on fecal samples from the low to moderate drinking (n=21) and non-drinking (n=72) groups. Results Comparison between groups using alpha and beta diversity showed that the diversity of stool microbiota in the low to moderate drinkinge group did not differ from that of the non-drinking group (all P >0.05). The Linear discriminant Analysis effect size (LEfSe) algorithm was to determine the bacterial taxa associated with alcohol consumption, and the results showed altered fecal bacterial composition in HIV-infected patients who consumed alcohol, with Coprobacillus , Pseudobutyrivibrio and Peptostreptococcaceae enriched, and Pasteurellaceae and Xanthomonadaceae were depleted. In addition, by using the Kyoto Encyclopedia of Genes and Genomes (KEGG) functional microbiome features were also found to be altered in the low to moderate drinking group, showing a reduction in metabolic pathways ( P =0.036) and cardiovascular disease pathway ( P =0.006). Conclusion Low to moderate drinking will change the composition, metabolism and cardiovascular disease pathway of the gut microbiota of HIV-infected patients.
pharmacology & pharmacy,toxicology,substance abuse
What problem does this paper attempt to address?